From Medscape Oncology

Coverage from the

Gastrointestinal Cancers Symposium (GICS) 2020

January 23 - 25, 2020; San Francisco, California

January 23 - 25, 2020 San Francisco, California

GICS 2020 Should Routine Colon Cancer Screening Start at 45, Not 50? The increase in colorectal cancer among younger adults has led to debate about lowering the age at which to begin screening.
Medscape Medical News, February 18, 2020
GICS 2020 'Important Conversations' About Cannabis With Cancer Patients Cancer patients are increasingly trying, and asking about, cannabis and cannabinoids. These are 'important conversations' for clinicians to be having.
Medscape Medical News, February 11, 2020
GICS 2020 Targeted Combos Improve QoL as Well as Survival in CRC Further analysis of data from the BEACON trial shows that targeted combinations improved quality of life as well as survival, but cost is a factor.
Medscape Medical News, January 28, 2020

Conference News

GICS 2020 Should Routine Colon Cancer Screening Start at 45, Not 50?
Medscape Medical News, February 18, 2020
GICS 2020 'Important Conversations' About Cannabis With Cancer Patients
Medscape Medical News, February 11, 2020
GICS 2020 Targeted Combos Improve QoL as Well as Survival in CRC
Medscape Medical News, January 28, 2020

GICS 2020 Gut Microbiome Link to Increased CRC in Younger Adults?
Medscape Medical News, January 27, 2020
GICS 2020 New Drug Combo Potentially Practice Changing in Advanced HCC
Medscape Medical News, January 27, 2020
GICS 2020 No Benefit With Boosted Radiation Dose in Esophageal Cancer
Medscape Medical News, January 24, 2020

Popular News from GICS 2019

'Impressive' Activity with BRAF/MEK Inhibitors in Biliary Cancer Combination therapy with dabrafenib and trametinib produced promising results in patients with advanced BRAF V600E-mutated biliary cancers.
Medscape Medical News, Jan 24, 2019
Survival Benefit With Combo Immunotherapy in Advanced CRC Combined durvalumab and tremelimumab improved overall survival in patients with advanced refractory colorectal cancer who were unselected for mismatch repair deficiency.
Medscape Medical News, Jan 23, 2019
Neoadjuvant Chemo Ups Survival in Pancreatic Cancer Neoadjuvant chemotherapy significantly improved overall survival in a cohort of Japanese patients and could be a new treatment option, but the regimen is not currently available in the US.
Medscape Medical News, Jan 22, 2019

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Expert Commentary

When a Promising Trial Fails, It Can Feel Personal
Mark A. Lewis, MD

Previous Coverage